UBAP2L: A Potential Drug Target and Biomarker (G9898)
UBAP2L: A Potential Drug Target and Biomarker
Uncovering the Potential of UBAP2L as a Drug Target and Biomarker
UBAP2L, or Ubiquitin-Binding Protein 2-like, is a protein that has been identified as a potential drug target and biomarker. It is a member of the Ubiquitin family of proteins, which are involved in a variety of cellular processes, including cell signaling, DNA repair, and protein degradation. TheUBAP2L gene has been shown to play a role in the regulation of cellular processes, and its function is still poorly understood.
UBAP2L is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, liver, and muscle. It is characterized by a unique N-terminal domain that consists of a single amino acid, known as D122, which is involved in the formation of a disulfide bond with a nearby amino acid, known as D123. The D122 and D123 bonds form a stable disulfide ring, which is thought to play a role in the protein's stability and functions.
UBAP2L has been shown to have a variety of functions in cellular processes. For example, it has been shown to be involved in the regulation of cell signaling pathways, including the Wnt signaling pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and maintenance of tissues and organs. UBAP2L has also been shown to be involved in the regulation of DNA repair, a process that is important for the maintenance of genetic integrity and the repair of DNA damage.
In addition to its role in cellular signaling pathways, UBAP2L has also been shown to be involved in the regulation of protein degradation. This is important for the regulation of cellular signaling pathways because it helps to ensure that the levels of signaling proteins are properly regulated.
The potential drug target for UBAP2L is its ability to interact with and modulate the activity of other proteins. This is known as Ubiquitin-Protein Ligase (UPL), which is a enzyme that is involved in the regulation of protein degradation. UPLs have been shown to play a key role in the regulation of cellular signaling pathways, and they are often used as drug targets for a variety of diseases, including cancer.
The potential biomarker for UBAP2L is its ability to serve as a protein target for drugs that can modulate the activity of UPLs. This is because UPLs are often involved in the regulation of protein degradation, and drugs that can modulate UPL activity can be effective in treating diseases that are characterized by the overproduction or underproduction of proteins.
UBAP2L has been shown to interact with a variety of proteins, including the transcription factor, p53. This suggests that it may play a role in the regulation of gene expression and that it may be a useful target for drugs that are designed to modulate gene function.
In addition to its potential as a drug target, UBAP2L may also be a useful biomarker for a variety of diseases. For example, it has been shown to be involved in the regulation of cell signaling pathways, which are often involved in the development and progression of diseases. This suggests that UBAP2L may be a useful biomarker for a variety of diseases, including cancer.
Conclusion
UBAP2L is a protein that has been identified as a potential drug target and biomarker. Its unique N-terminal domain, which consists of a single amino acid, D122, that is involved in the formation of a disulfide bond with a nearby amino acid, D123, is thought to play a role in the protein's stability and functions. UBAP2L has been shown to have a variety of functions in cellular processes, including the regulation of cell signaling pathways and the regulation of protein degradation. The potential drug target for UBAP2L is its ability to interact with and modulate the activity of other proteins, including the transcription factor, p53. The potential biomarker for UBAP2
Protein Name: Ubiquitin Associated Protein 2 Like
Functions: Recruits the ubiquitination machinery to RNA polymerase II for polyubiquitination, removal and degradation, when the transcription-coupled nucleotide excision repair (TC-NER) machinery fails to resolve DNA damage (PubMed:35633597). Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (By similarity). Required for efficient formation of stress granules (PubMed:29395067)
More Common Targets
UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A | UBE2B | UBE2C | UBE2CP3 | UBE2CP4 | UBE2D1 | UBE2D2 | UBE2D3 | UBE2D3P1 | UBE2D4 | UBE2DNL | UBE2E1 | UBE2E2 | UBE2E3 | UBE2F | UBE2F-SCLY | UBE2FP1 | UBE2G1 | UBE2G2 | UBE2H | UBE2HP1 | UBE2I | UBE2J1 | UBE2J2 | UBE2K | UBE2L1 | UBE2L3 | UBE2L6 | UBE2M | UBE2MP1 | UBE2N | UBE2NL | UBE2O | UBE2Q1 | UBE2Q2 | UBE2Q2P1 | UBE2Q2P11 | UBE2Q2P13 | UBE2Q2P16 | UBE2Q2P2 | UBE2QL1 | UBE2R2 | UBE2R2-AS1 | UBE2S | UBE2T | UBE2U | UBE2V1 | UBE2V1P2 | UBE2V1P9 | UBE2V2 | UBE2V2P1 | UBE2W | UBE2Z | UBE3A | UBE3B | UBE3C | UBE3D | UBE4A | UBE4B | UBFD1 | UBIAD1 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 | Ubiquitin E3 ligase (ASB2, TCEB1, TCEB2, CUL5, RNF7) complex | UBL3 | UBL4A | UBL4B | UBL5 | UBL5P3 | UBL7 | UBL7-DT | UBLCP1 | UBN1 | UBN2 | UBOX5 | UBOX5-AS1 | UBP1 | UBQLN1 | UBQLN1-AS1 | UBQLN2 | UBQLN3 | UBQLN4 | UBQLNL | UBR1 | UBR2 | UBR3 | UBR4 | UBR5 | UBR5-DT | UBR7 | UBTD1 | UBTD2